Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic.
Lalani AA, Chi KN, Heng DYC, Kollmannsberger CK, Sridhar SS, Blais N, Canil C, Czaykowski P, Hotte SJ, Iqbal N, Soulières D, Bossé D, Alimohamed NS, Basappa NS, Mukherjee SD, Winquist E, Wood LA, North SA. Lalani AA, et al. Can Urol Assoc J. 2020 May;14(5):E154-E158. doi: 10.5489/cuaj.6595. Epub 2020 Apr 5. Can Urol Assoc J. 2020. PMID: 32267828 Free PMC article. No abstract available.
Immunotherapy in the Elderly.
Lalani AA, Bossé D, McGregor BA, Choueiri TK. Lalani AA, et al. Eur Urol Focus. 2017 Oct;3(4-5):403-412. doi: 10.1016/j.euf.2017.11.008. Epub 2017 Nov 26. Eur Urol Focus. 2017. PMID: 29183736 Review.
Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma.
Mason RJ, Wood L, Kapoor A, Basappa N, Bjarnason G, Boorjian SA, Breau RH, Cagiannos I, Jewett MAS, Karakiewicz PI, Kassouf W, Kollmannsberger C, Lalani AA, Lattouf JB, Lavallée LT, Pautler S, Power N, Richard P, So A, Tanguay S, Rendon RA. Mason RJ, et al. Among authors: lalani aa. Can Urol Assoc J. 2019 Jun;13(6):166-174. doi: 10.5489/cuaj.5786. Can Urol Assoc J. 2019. PMID: 31199235 Free PMC article. No abstract available.
Response of Primary Renal Cell Carcinoma to Systemic Therapy.
Bossé D, Lin X, Simantov R, Lalani AA, Derweesh I, Chang SL, Choueiri TK, McKay RR. Bossé D, et al. Among authors: lalani aa. Eur Urol. 2019 Dec;76(6):852-860. doi: 10.1016/j.eururo.2019.08.035. Epub 2019 Oct 6. Eur Urol. 2019. PMID: 31594707
Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.
Hotte SJ, Kapoor A, Basappa NS, Bjarnason G, Canil C, Conter HJ, Czaykowski P, Graham J, Gray S, Heng DYC, Karakiewicz PI, Kollmannsberger C, Lalani AA, North SA, Patenaude F, Soulières D, Violette P, Winquist E, Wood LA, Dudani S, Maloni R, Reaume MN; Kidney Cancer Research Network of Canada. Hotte SJ, et al. Among authors: lalani aa. Can Urol Assoc J. 2019 Oct;13(10):343-354. doi: 10.5489/cuaj.6256. Can Urol Assoc J. 2019. PMID: 31603413 Free PMC article. No abstract available.
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum.
Saad F, Canil C, Finelli A, Hotte SJ, Malone S, Shayegan B, So AI, Aaron L, Basappa NS, Conter HJ, Danielson B, Gotto G, Hamilton RJ, Izard JP, Kapoor A, Kolinsky M, Lalani AA, Lattouf JB, Morash C, Morgan SC, Niazi T, Noonan KL, Ong M, Rendon RA, Sehdev S, Hew H, Park-Wyllie L, Chi KN. Saad F, et al. Among authors: lalani aa. Can Urol Assoc J. 2020 Apr;14(4):E137-E149. doi: 10.5489/cuaj.6082. Epub 2019 Nov 5. Can Urol Assoc J. 2020. PMID: 31702544 Free PMC article. Review.
Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer.
Nguyen EK, Yu H, Pond G, Shayegan B, Pinthus JH, Kapoor A, Mukherjee SD, Neville A, Lalani AA, Hotte SJ, Corbett TB, Dayes IS, Lukka HR. Nguyen EK, et al. Among authors: lalani aa. Can Urol Assoc J. 2020 Apr;14(4):122-129. doi: 10.5489/cuaj.5945. Epub 2019 Nov 5. Can Urol Assoc J. 2020. PMID: 31702551 Free PMC article.
Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts.
Bossé D, Xie W, Lin X, Simantov R, Lalani AA, Graham J, Wells JC, Donskov F, Rini B, Beuselinck B, Alva A, Hansen A, Wood L, Soulières D, Kollmannsberger C, Patenaude F, Heng DYC, Choueiri TK, McKay RR. Bossé D, et al. Among authors: lalani aa. JCO Glob Oncol. 2020 Feb;6:293-306. doi: 10.1200/JGO.19.00380. JCO Glob Oncol. 2020. PMID: 32109159 Free PMC article.
49 results